[{"address1": "4200 Marathon Boulevard", "address2": "Suite 200", "city": "Austin", "state": "TX", "zip": "78756", "country": "United States", "phone": "512 215 2630", "website": "https://lumos-pharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of products and therapies for people with rare diseases. Its primary product candidate is LUM-201, an oral growth hormone secretagogue ibutamoren, which is in Phase III clinical trial for the treatment of idiopathic pediatric growth hormone deficiency and other rare endocrine disorders. The company has a clinical collaboration with Massachusetts General Hospital to evaluate oral LUM-201 in nonalcoholic fatty liver disease. Lumos Pharma, Inc. is headquartered in Austin, Texas. As of December 12, 2024, Lumos Pharma, Inc. was taken private.", "fullTimeEmployees": 30, "companyOfficers": [{"maxAge": 1, "name": "Mr. Richard J. Hawkins", "age": 74, "title": "Founder, CEO & Chairman", "yearBorn": 1949, "fiscalYear": 2023, "totalPay": 854352, "exercisedValue": 0, "unexercisedValue": 26296}, {"maxAge": 1, "name": "Dr. John C. McKew Ph.D.", "age": 59, "title": "Chief Scientific Officer & President", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 860382, "exercisedValue": 0, "unexercisedValue": 11771}, {"maxAge": 1, "name": "Ms. Lori D. Lawley CPA", "age": 39, "title": "CFO & Principal Accounting Officer", "yearBorn": 1984, "fiscalYear": 2023, "totalPay": 538229, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lisa Wells Miller", "title": "Senior Director of Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bradley J. Powers J.D.", "age": 44, "title": "Chief Compliance Officer & General Counsel", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 677078, "exercisedValue": 0, "unexercisedValue": 234894}, {"maxAge": 1, "name": "Mr. Aaron  Schuchart B.B.A., CPA, M.B.A.", "age": 57, "title": "Chief Business Officer", "yearBorn": 1966, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Pisit  Pitukcheewanont FAAP, M.D.", "title": "Chief Medical Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Alpa  Parikh", "title": "Senior Vice President of CMC & Supply Management", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Eddie L. Varnado M.B.A.", "title": "Corporate Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 4.34, "open": 4.33, "dayLow": 4.34, "dayHigh": 4.34, "regularMarketPreviousClose": 4.34, "regularMarketOpen": 4.33, "regularMarketDayLow": 4.34, "regularMarketDayHigh": 4.34, "beta": 0.331, "forwardPE": -2.2199488, "volume": 390873, "regularMarketVolume": 390873, "averageVolume": 102979, "averageVolume10days": 138391, "averageDailyVolume10Day": 138391, "marketCap": 37535012, "fiftyTwoWeekLow": 1.3701, "fiftyTwoWeekHigh": 4.5756, "priceToSalesTrailing12Months": 17.02268, "fiftyDayAverage": 4.231046, "twoHundredDayAverage": 3.095614, "currency": "USD", "enterpriseValue": 24188002, "floatShares": 5661558, "sharesOutstanding": 8648620, "sharesShort": 54328, "sharesShortPriorMonth": 86380, "sharesShortPreviousMonthDate": 1730332800, "dateShortInterest": 1732838400, "sharesPercentSharesOut": 0.0063, "heldPercentInsiders": 0.32694, "heldPercentInstitutions": 0.24271, "shortRatio": 0.59, "shortPercentOfFloat": 0.0087, "impliedSharesOutstanding": 8648620, "bookValue": 0.568, "priceToBook": 7.6408453, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -34916000, "trailingEps": -4.28, "forwardEps": -2.16, "lastSplitFactor": "1:9", "lastSplitDate": 1584576000, "enterpriseToRevenue": 10.97, "enterpriseToEbitda": -0.666, "52WeekChange": 0.36477983, "SandP52WeekChange": 0.25443196, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "LUMO", "underlyingSymbol": "LUMO", "shortName": "Lumos Pharma, Inc.", "longName": "Lumos Pharma, Inc.", "firstTradeDateEpochUtc": 1321021800, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "bcffe56f-50ef-3693-86d2-3838602f9308", "messageBoardId": "finmb_256380672", "gmtOffSetMilliseconds": -18000000, "currentPrice": 4.34, "targetHighPrice": 4.25, "targetLowPrice": 4.25, "targetMeanPrice": 4.25, "targetMedianPrice": 4.25, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 13519000, "totalCashPerShare": 1.563, "ebitda": -36308000, "totalDebt": 172000, "quickRatio": 2.105, "currentRatio": 2.655, "totalRevenue": 2205000, "debtToEquity": 3.5, "revenuePerShare": 0.27, "returnOnAssets": -0.69636, "returnOnEquity": -1.72826, "freeCashflow": -19431624, "operatingCashflow": -31673000, "revenueGrowth": 102.714, "grossMargins": 1.0, "operatingMargins": -10.52342, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-01-02"}]